Specialty medications
Launch a focused formulary of immunotherapies and monoclonal antibodies suited to the hospital's existing infusion capabilities.
Oncology infusion for Critical Access Hospitals
Specialty pharmacy,
integrated within your facility.
Varick enables Critical Access Hospitals to deliver specialty oncology medications in their own infusion suites. Credentialed telehealth oncologists consult, prescribe, review each cycle, and oversee treatment while Varick manages access and operations.
In-house infusion
specialty medications delivered locally
Telehealth oncology
specialist oversight by video
8-12 weeks
from assessment to first infusion
The opportunity
Your Critical Access Hospital may already have most of what oncology infusion needs.
Patients are often referred out for oncology care despite having local infusion capacity.
Varick supplies those pieces so you can purchase the specialty medication, administer the infusion in-house, care for the patient locally, and retain 340B revenue.
Telehealth oncology
Credentialed specialists consult, prescribe, review labs, and oversee treatment virtually as members of the local care team.
In-house infusion
Pharmacy and nursing teams prepare and administer treatment locally with specialty workflows, clinical protocols, and real-time oversight.
Access and operations
Prior authorization, payer follow-up, 340B tracking, appeals, and program operations are managed end to end.
How in-house infusion works
Telehealth brings the oncologist in. Specialty treatment stays local.
A credentialed oncologist becomes a virtual member of the hospital care team: consulting, prescribing, reviewing each cycle, and staying available during infusion while local teams care for the patient in person.
-
01
Patient arrives locally
Records, imaging, and labs are prepared by the local team.
-
02
Oncologist consults
A credentialed specialist evaluates the patient by secure video.
-
03
Treatment is ordered
The plan and prescription are signed and sent to the hospital pharmacy.
-
04
Pharmacy prepares
The specialty medication is purchased, tracked, and prepared in-house.
-
05
RN administers
The infusion team monitors vitals, tolerability, and reactions on site.
-
06
Specialist oversees
The oncologist remains available and reviews each cycle remotely.
Revenue estimator
Choose a drug. See the opportunity.
Select one oncology therapy and enter the number of qualifying patients. Varick applies a conservative annual 340B value per patient.
Oncology
Keytruda
pembrolizumab
J9271
J-code
$70,000
Annual value / patient
NSCLC, melanoma, solid tumors
Primary indication
How many qualifying patients receive this drug?
patients
Directional estimate only. Per-patient values are conservative annual 340B spread assumptions for qualifying private insurance and Medicare Advantage claims. Actual acquisition cost, reimbursement, eligibility, dosage, payer mix, and treatment duration vary. Traditional Medicare reimbursement may follow different cost-based rules.
A focused in-house formulary
Start with the specialty medications your hospital can support today.
Varick starts with selected immunotherapies and monoclonal antibodies that fit a USP 797 sterile preparation environment, allowing Critical Access Hospitals to begin in-house oncology infusion without first building a traditional cytotoxic chemotherapy program.
USP 797
Sterile preparation workflows for the initial formulary
340B
Program tracking and compliant operating support
J-code
Medical-benefit billing through the outpatient hospital
From assessment to infusion
A practical 12-week path to launch.
We coordinate the clinical, payer, pharmacy, and operating workstreams so the program advances as one launch, not a collection of side projects.
Phase 0
Weeks 1-3
Assess
Confirm pharmacy readiness, referral leakage, payer mix, licensing, and 340B status.
Phase 1
Weeks 3-7
Build
Establish workflows, payer credentialing, prior authorization, equipment, and clinical protocols.
Phase 2
Weeks 7-12
Launch
Activate the remote oncology panel, begin treatment, bill claims, and manage denials.
Ongoing
Post-launch
Scale
Expand the formulary, specialist panel, integrations, and local oncology reach.
Bring oncology infusion in-house
Build the specialty oncology program your region needs.
Start with your referral volume, payer mix, and existing pharmacy infrastructure. We will help you see the path forward.
Talk with Varick